Go to the list of all blogs
Anna G's Avatar
published in Blogs
Oct 15, 2023

Medical Distributors Surge: $CAH, $ZYXI, $PDCO, $COR, $MCK Gain +3.18%

Medical Distributors Surge: A Deeper Dive into Market Movements and Notable Tickers

πŸ“ˆ Medical Distributors experience a +3.18% gain in the past month. Current Buy/Sell Ratings suggest a Positive Outlook for stocks in the group.

Are you interested in the dynamic world of medical distributors and eager to optimize your trading strategies within this sector? Look no further! Our AI robots are tailored to meet your trading needs in the Group Medical Distributors arena.

πŸ€– "Swing Trader, Popular Stocks: Price Action Trading Strategy (TA&FA)" provides you with a reliable and data-driven approach to trading within this sector. Whether you're a seasoned trader or just starting, this AI tool can assist you in making informed decisions.

πŸ’Ό For those seeking to capitalize on upward market trends, "Swing Trader for Beginners: Trading in Markets Trending Up (TA&FA)" offers a simplified yet effective strategy. It's designed to empower traders to navigate and thrive in markets on the rise.

With these AI robots by your side, you'll be well-equipped to explore trading opportunities and make data-backed decisions in the ever-evolving world of medical distributors. Elevate your trading game today!

Tickers in this Group:Β 
$EDAPΒ - $CAHΒ - $MCKΒ - $CORΒ -Β $HSICΒ -Β  $OMIΒ -Β $PDCOΒ - $ZYXI

The Landscape of Medical Distributors

Medical distributors play a pivotal role in the healthcare ecosystem, bridging the gap between manufacturers and providers. Their core services, ranging from product distribution to inventory management, contribute significantly to the US healthcare sector's value. As per a report by Deloitte, these services infuse a value of $33 billion-$53 billion annually. Major players in this sector include giants like McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc., and Patterson Companies, Inc.

Market Cap: The Financial Magnitude

The medical distributors' industry has a collective market cap averaging at 8.9B. The spectrum is vast - from $MCK at a towering 61.9B to a modest $SNYR at 494.4K.

High and Low Price Notable News: The Peaks and Valleys

  • Average weekly price growth: 2.39%
  • Average monthly price growth: 2.09%
  • Quarterly spike: 11.3%

Key Players:

  • $EXHID soars with the highest growth at 37.25%
  • $OMI takes a dip at -4.39%

Recent News Highlights:

  • 10/11/23: $CAH leaps with a +5.51% weekly increase.
  • 8/18/23: Both $OMI and $CAH saw declines, dropping by -14.46% and -6.44%, respectively.

Volume: The Trading Buzz

  • Weekly volume decline: -7.21%
  • Monthly volume decline: -56.61%
  • Quarterly volume increment: 0.2%

Fundamental Analysis Ratings: The Deep Dive

  • Valuation Rating: 66
  • P/E Growth Rating: 51
  • Price Growth Rating: 56
  • SMR Rating: 66
  • Profit Risk Rating: 73
  • Seasonality Score: 27 (Scale: -100 to +100)

Ticker Descriptions: Highlighting Key Players

πŸ” $CAH: Now trending upward after rising above its 50-day MA on October 04, 2023. Past trends suggest a 78% chance of continued uptrend.

πŸ” $ZYXI: Watch out! Entering the oversold zone as of October 13, 2023. Historically, it indicates potential for a price uptrend or consolidation soon.

πŸ” $PDCO: Positive vibes! MACD Histogram turned positive on September 21, 2023, with 82% chances of a continued rise.

πŸ” $COR: Bullish trend with the 10-day MA crossing over the 50-day MA on September 28, 2023. Past data indicates a 71% chance of continued upward movement.

πŸ” $MCK: Yet another MACD positive shift on September 12, 2023, with a strong 75% odds of maintaining the bullish trend.

πŸ” $EDAP: Positive MACD crossover on September 20, 2023, suggests an 84% probability of an upward trend in the coming month.

Β 

The Medical Distributors sector is currently buzzing with positive vibes, reflected in its impressive gains and overall positive outlook. Traders should closely monitor the described tickers and watch for further market shifts. As always, it's essential to make informed decisions and keep an eye on these notable market movers. Happy trading! πŸ“ŠπŸ“‰πŸ“ˆ

Related Ticker: FOCL, CAH, MCK, COR, HSIC, OMI, PDCO, ZYXI

FOCL's RSI Oscillator stays in oversold zone for 1 day

It is expected that a price bounce should occur soon.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 55 cases where FOCL's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on September 04, 2026. You may want to consider a long position or call options on FOCL as a result. In of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where FOCL advanced for three days, in of 248 cases, the price rose further within the following month. The odds of a continued upward trend are .

FOCL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for FOCL turned negative on August 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 40 similar instances when the indicator turned negative. In of the 40 cases the stock turned lower in the days that followed. This puts the odds of success at .

FOCL moved below its 50-day moving average on August 12, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for FOCL crossed bearishly below the 50-day moving average on August 18, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 11 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FOCL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for FOCL entered a downward trend on September 02, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. FOCL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: FOCL's P/B Ratio (17.212) is slightly higher than the industry average of (7.846). FOCL has a moderately low P/E Ratio (0.000) as compared to the industry average of (20.007). FOCL's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (1.358). FOCL's Dividend Yield (0.000) is considerably lower than the industry average of (0.006). P/S Ratio (1.961) is also within normal values, averaging (4.372).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FOCL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock worse than average.

Notable companies

The most notable companies in this group are McKesson Corp (NYSE:MCK).

Industry description

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

Market Cap

The average market capitalization across the Medical Distributors Industry is 21.6B. The market cap for tickers in the group ranges from 557.05K to 105.86B. MCK holds the highest valuation in this group at 105.86B. The lowest valued company is CNBI at 557.05K.

High and low price notable news

The average weekly price growth across all stocks in the Medical Distributors Industry was -3%. For the same Industry, the average monthly price growth was -16%, and the average quarterly price growth was -26%. COSM experienced the highest price growth at 22%, while HKPD experienced the biggest fall at -65%.

Volume

The average weekly volume growth across all stocks in the Medical Distributors Industry was -8%. For the same stocks of the Industry, the average monthly volume growth was -27% and the average quarterly volume growth was 968%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 57
P/E Growth Rating: 59
Price Growth Rating: 64
SMR Rating: 88
Profit Risk Rating: 74
Seasonality Score: -4 (-100 ... +100)
View a ticker or compare two or three
FOCL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a developer of minimally invasive medical devices for urological diseases

Industry MedicalDistributors

Profile
Details
Industry
Biotechnology
Address
Parc d'Activites La Poudrette-Lamartine
Phone
+33 472153150
Employees
289
Web
http://www.focalone.com
Interact to see
Advertisement
Palantir (PLTR) is outperforming a struggling market, rallying strongly over the past few sessions while approaching a critical resistance level near $143. With geopolitical tensions rising and defense analytics demand growing, the stock sits at a pivotal technical moment that could determine its next major move.
Investors holding record levels of protective puts means downside is heavily hedged, which often dampens crash risk but supports higher implied volatility (VIX) in the short run. The fact that the S&P 500 and Nasdaq are rising while hedging is surging suggests a β€œwall of worry” market: people are bullish enough to stay in, but nervous enough to pay up for insurance.
During the week of 9–15 February 2026, major U.S. equity indices finished lower overall, while Tickeron’s trending AI trading bots produced positive returns, particularly in defense and energyβ€”two areas now directly affected by the newly opened war in Iran. With macro risk rising and volatility picking up, this divergence matters: it shows how sector‑focused, rules‑based AI strategies can still find upside when broad index exposure is negative.
Investors are furiously hedging against a potential credit market crash, just as geopolitical risk explodes with a new war in Iran. Put option open interest on major U.S. credit ETFs like HYG, JNK, LQD, and BKLN has surged to a record ~11.5 million contracts, doubling over the last 12 months and already exceeding the 2022 bear‑market peak of 10 million.
The current gap between single‑stock implied volatility and index volatility is back near October 2008 extremes, signaling that investors expect idiosyncratic risk (stock‑specific jumps) to dominate.
The HUBB/AVGO/ITA/QQQ robot is a multi-sector swing trader with a 5-minute entry / daily exit structure, capturing macro megatrends across defense, semiconductors, infrastructure, and growth tech. The LRCX/TER/AMAT/KLAC/AMKR/ASML robot is a concentrated intraday-to-swing trader operating exclusively in semiconductor equipment β€” one of the highest-volatility sectors in the market β€” on a 60-minute timeframe.
Tickeron's Defense PPA AI Trading Agent is an automated swing trading system focused exclusively on PPA β€” the Invesco Aerospace & Defense ETF. Designed with a 60-minute entry timeframe and daily timeframe exit signals, the robot balances intraday precision with longer-duration swing holding, allowing it to capture meaningful price moves in one of the most momentum-driven sectors of 2025–2026.
MRNA surged approximately +16.07% on March 4, 2026, closing at $57.84, up from the prior session's close of $49.83. The primary catalyst was Moderna's announcement of a landmark settlement in its long-running patent dispute over lipid nanoparticle (LNP) technology used in its mRNA vaccines.
Shares of The Trade Desk (TTD) surged +28.05% on March 5, 2026, reaching $32.23 from a prior close of $25.17. The primary catalyst was CEO Jeff Green's record insider purchase of approximately 6 million shares worth ~$148 million β€” the largest insider buy in the company's history.
AEO shares are trading at $19.89, down $2.56 or -11.40% from the prior session's close of $22.45. The primary catalyst is deeply disappointing Q1 fiscal 2026 operating income guidance of just $20–$25 million, which badly missed analyst expectations.
CIEN shares plunged 14.25% on March 5, 2026, trading at $294.59 versus the prior session's close of $343.55 β€” a decline of $48.96 per share. The steep sell-off came despite a strong earnings beat: adjusted EPS of $1.35 crushed the consensus estimate of $1.05 by 28.6%, and revenue of $1.43 billion rose 33% year-over-year.
Shares of Victoria's Secret & Co. (VSCO) tumbled approximately 11.87% in early trading on March 5, falling from a prior close of $60.01 to an intraday price near $52.89, with an intraday low of $51.61. The steep decline came despite a Q4 2025 earnings beat, with adjusted EPS of $2.77 topping the consensus estimate of $2.46 and revenue of $2.27 billion exceeding the expected $2.22 billion.
AMPX shares surged +18.57% in today's session, trading at $14.88 versus the prior close of $12.55. Primary catalyst: Q4 and full-year fiscal 2025 earnings, reported before the open, delivered a decisive beat on both EPS and revenue expectations.
EXPE shares are trading up approximately +9.70% intraday on March 5, 2026, rising from a prior close of $221.25 to around $242.71. March 5 is the stock's ex-dividend date for a newly raised quarterly dividend of $0.48 per share β€” a 20% increase from the prior payout β€” signaling strong management confidence in cash generation.
SES shares are down approximately 30% intraday on Thursday, March 5, 2026, trading near $1.19 against the prior session's close of $1.71. The primary catalyst is deeply disappointing 2026 revenue guidance of $30–$35 million β€” roughly 41% below the Wall Street consensus of $51.67 million.
What if a single trading robot could harvest volatility across semiconductors, oil, and communication technology β€” simultaneously β€” while filtering out the noise that burns most active traders? That's exactly what the Semiconductors, Oil & Energy, Communication Tech AI Trading Agent delivers. Over the past 364 days (March 5, 2025 – March 4, 2026), this agent generated a Total Net Profit of $20,641.78 on $500-per-trade sizing β€” an eye-catching Annualized Return of 68.58%. With 1,534 closed trades, a 61.86% win rate, and a dominant Profit Factor of 3.02
What if an AI trading agent could turn market chaos into a 45.55% annualized return? That's exactly what Tickeron's HUBB, AVGO, ITA, QQQ – AI Trading Agent (4 Tickers, 5min) has delivered across 106 days of live trading β€” posting $11,605.87 in total net profit from a per-trade allocation of $2,500–$8,250, a 69.59% win rate across 444 closed trades, and a Profit Factor of 2.18.
83.97% Win Rate | 87.10% Annualized Return | $44,879.15 Total Net Profit | Profit Factor: 4.92 | Sharpe Ratio: 1.13
HYMC’s latest sell‑off is part of a broader downtrend that accelerated after the company delayed its PEA, which investors interpreted as an uncertainty event despite no immediate change in reported resources or cash position. Technical indicators such as HYMC breaking above its upper Bollinger Band and then rolling over, along with the Aroon indicator turning down in late February, signaled an elevated risk of a sharp pullback that is now playing out.
DSGR reported quarterly EPS of about 0.18 dollars, badly missing consensus estimates of roughly 0.32–0.33 dollars per share and marking a sharp drop from 0.42 dollars a year ago, which triggered a large negative earnings surprise. Revenue of about 481–482 million dollars came in below expectations near 496 million dollars, and adjusted EBITDA margins compressed to about 7.4% from 9.3% in the prior‑year quarter, highlighting cost and mix pressures.